Mecklenburg Medical Group Trials

Mecklenburg Medical Group	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Contact, Site Public

NCT03824522: Post Marketing Surveillance Study for ADYNOVATE in South Korea

Completed

N/A

341

RoW

ADYNOVATE, PEGylated rFVIII

Takeda, Takeda Pharma Korea Co. Ltd.

Hemophilia A

01/24

NCT04885920: A Study on Administration Choices of Vedolizumab and Outcomes for Adults With Inflammatory Bowel Disease (IBD) (VARIETY - CROATIA AND SLOVENIA)

Completed

N/A

120

Europe, RoW

Takeda

Inflammatory Bowel Diseases, Crohns Disease, Colitis, Ulcerative

03/24

HN-STAR, NCT04208490: Implementation and Effectiveness Trial of

Recruiting

N/A

470

HN-STAR Intervention

Wake Forest University Health Sciences, National Cancer Institute (NCI), Memorial Sloan Kettering Cancer Center

Head and Neck Cancer

09/25

CREDIT, NCT05288491: A Study of Chinese Adults With Lymphoma

Recruiting

N/A

1000

RoW

Takeda

Lymphoma

06/24

NCT06295367: Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)

Recruiting

N/A

760

Best Practice, standard of care, standard therapy, Financial Navigation, Financial Navigation Program, Interview, Survey Administration

ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)

Malignant Solid Neoplasm

12/27

NCT05371028: A Study of Teduglutide (Revestive®) in Participants With Short Bowel Syndrome (SBS) in Canada

Recruiting

N/A

100

Canada

Non-interventional Study

Takeda

Short Bowel Syndrome (SBS)

07/24

NCT05106764: Early Detection of Fabry Disease

Active, not recruiting

N/A

Europe

No intervention

Takeda

Fabry Disease

04/24

NCT02474160: Collection and Storage of Tissue and Blood Samples From Patients With Cancer

Recruiting

N/A

5000

Cytology Specimen Collection Procedure, Cytologic Sampling

National Cancer Institute (NCI)

Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm

05/26

NCT04861233: A Study of Lubiprostone to Treat Constipation

Recruiting

N/A

3000

RoW

No Intervention

Jeil Pharmaceutical Co., Ltd.

Constipation

05/24

11/24

NCT04872491: A Study of Vedolizumab in Adults in Real-World Practice

Active, not recruiting

N/A

500

RoW

Takeda

Colitis, Ulcerative, Crohn Disease

07/24

DRALEGA, NCT05982717: A Study to Gather Information About Overall Occurrence and New Cases of Dravet and Lennox-Gastaut Syndromes in Children, Teenagers and Adults in Spain

Recruiting

N/A

250

Europe

No intervention

Takeda

Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS)

05/24

MiCHOICE, NCT04496739: Making Informed Choices on Incorporating Chemoprevention Into Care

Recruiting

N/A

415

US, RoW

Cancer Educational Materials, Decision Aid, Interview, Questionnaire Administration

SWOG Cancer Research Network, National Cancer Institute (NCI)

Atypical Hyperplasia of the Breast, Lobular Breast Carcinoma In Situ, Pleomorphic Lobular Breast Carcinoma In Situ

05/25

06/28

NCT04840680: A Study of Real-World Use of Ixazomib Citrate in People With Multiple Myeloma (MM)

Recruiting

N/A

165

RoW

No Intervention

Takeda

Multiple Myeloma

06/24

NCT04467021: Cancer and Blood Pressure Management, CARISMA Study

Active, not recruiting

N/A

Best Practice, standard of care, standard therapy, Blood Pressure Measurement, Clinical Management, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration

ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)

Cardiovascular Disorder, Chronic Kidney Disease, Metastatic Renal Cell Carcinoma, Metastatic Thyroid Gland Medullary Carcinoma, Stage IV Renal Cell Cancer AJCC v8, Stage IV Thyroid Gland Medullary Carcinoma AJCC v8, Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8, Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8, Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8

12/24

NCT05886478: A Study in Adults With Cutaneous T-cell Lymphoma (CTCL) Retreated With Brentuximab Vedotin

Recruiting

N/A

Europe

No intervention

Takeda

T-Cell Lymphoma

06/24

mECHromatic, NCT05755568: A Study to Learn About Metachromatic Leukodystrophy (MLD) in Children in Spain

Withdrawn

N/A

Europe

No Intervention

Takeda

Metachromatic Leukodystrophy (MLD)

07/24

NCI-2022-03576, NCT05359237: Vincristine Pharmacokinetics in Infants

Recruiting

N/A

Canada, US, RoW

Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Vincristine, LCR, Leurocristine, VCR, Vincrystine

Children's Oncology Group, National Cancer Institute (NCI)

Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm

07/24

NCT03697148: Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer

Recruiting

N/A

852

Multiparametric Magnetic Resonance Imaging, MP-MRI, Multi-parametric MRI, Multiparametric MRI

ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)

Prostate Carcinoma

12/24

08/25

NCT06346899: A Study of Lanadelumab (Takhzyro) and Icatibant (Firazyr®) in Persons With HAE in China

Not yet recruiting

N/A

130

RoW

No intervention

Takeda

Hereditary Angioedema (HAE)

08/25

ENABLE, NCT04130191: A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II

Active, not recruiting

N/A

140

Europe, RoW

Shire, Takeda Development Center Americas, Inc.

Hereditary Angioedema (HAE)

09/24

LANDSCAPE, NCT04943796: A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life

Recruiting

N/A

576

Europe, Canada

Takeda

Attention Deficit Hyperactivity Disorder (ADHD)

09/24

IMPACTS, NCT04462302: An Internet-based Program to Help Cancer Survivors Manage Pain

Recruiting

N/A

456

Internet-based pain coping skills program

Wake Forest University Health Sciences, National Cancer Institute (NCI), National Institute of Neurological Disorders and Stroke (NINDS)

Cancer

10/24

04/25

INFINITE, NCT04328662: A Study of Ninlaro in Real World Clinical Practice in China

Recruiting

N/A

3000

RoW

Takeda

Multiple Myeloma, Neoplasms, Plasma Cell

09/25

NCT06104878: A Study in Adults With Advanced Classical Hodgkin's Lymphoma (cHL) in Brazil Treated With Brentuximab Vedotin Together With Chemotherapy Compared to Chemotherapy Alone

Withdrawn

N/A

200

RoW

No Intervention

Takeda

Hodgkin Lymphoma

10/24

NCT05108298: Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Recruiting

N/A

400

Questionnaires

Eastern Cooperative Oncology Group

Breast Cancer, NOS, CNS Primary Tumor, NOS, Cervical Cancer, NOS, Colorectal Cancer, NOS, Leukemia, NOS, Lymphoma, NOS, Miscellaneous Neoplasm, NOS, Non-Rhabdomyosarcoma Soft Tissue Sarcoma, NOS, Testicular Nonseminomatous Germ Cell Tumor, NOS, Thyroid Cancer, NOS, Melanoma, Bone Cancer, NOS

11/24

ELEGANT, NCT05737849: A Study to Learn About the Tests Looking for a Gene Mutation in Adults With Lung Cancer in China

Withdrawn

N/A

10800

RoW

No Intervention

Takeda

Non-small Cell Lung Cancer (NSCLC)

12/24

NCT05228275: Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer

Recruiting

N/A

549

Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Survey Administration

Children's Oncology Group, National Cancer Institute (NCI)

COVID-19 Infection, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm

09/27

NCT04837222: A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma

Recruiting

N/A

1000

RoW

No Intervention

Takeda

Lymphoma

01/25

SUNRISE, NCT05192863: A Study of Vedolizumab in Adults With Crohn's Disease (CD)

Active, not recruiting

N/A

Europe, Canada, RoW

No Intervention

Takeda

Crohn's Disease

01/25

PEDS, NCT04721366: A Study of Velaglucerase Alfa (VPRIV) Given as Standard Patient Care in Young Children With Gaucher Disease

Completed

N/A

Standard of Care, SOC

Takeda

Gaucher Disease

04/23

NCT05626088: A Study in Adults With Inflammatory Bowel Disease (IBD) Receiving Vedolizumab in the Patient Support Program (PSP) in Brazil

Recruiting

N/A

2160

RoW

No Intervention

Takeda

Ulcerative Colitis, Crohn's Disease

01/25

NCT05334069: Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Recruiting

N/A

2000

Questionnaire Administration, Biospecimen Collection

Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Ann Arbor Stage I Lymphoma, Ann Arbor Stage II Lymphoma, Ann Arbor Stage III Lymphoma, Ann Arbor Stage IV Lymphoma, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Gastroesophageal Junction Adenocarcinoma, Head and Neck Carcinoma, Hematopoietic and Lymphoid Cell Neoplasm, Invasive Breast Carcinoma, Kidney Carcinoma, Malignant Hepatobiliary Neoplasm, Malignant Solid Neoplasm, Melanoma, Muscle-Invasive Bladder Carcinoma, RISS Stage I Plasma Cell Myeloma, RISS Stage II Plasma Cell Myeloma, RISS Stage III Plasma Cell Myeloma, Sarcoma, Stage I Bladder Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7, Stage I Colorectal Cancer AJCC v6 and v7, Stage I Esophageal Cancer AJCC V7, Stage I Gastric Cancer AJCC V7, Stage I Lung Cancer AJCC v7, Stage I Ovarian Cancer AJCC v6 and v7, Stage I Pancreatic Cancer AJCC v6 and v7, Stage I Prostate Cancer AJCC v7, Stage I Uterine Corpus Cancer AJCC v7, Stage II Bladder Cancer AJCC v6 and v7, Stage II Breast Cancer AJCC v6 and v7, Stage II Colorectal Cancer AJCC v7, Stage II Esophageal Cancer AJCC v7, Stage II Gastric Cancer AJCC v7, Stage II Lung Cancer AJCC v7, Stage II Ovarian Cancer AJCC v6 and v7, Stage II Pancreatic Cancer AJCC v6 and v7, Stage II Prostate Cancer AJCC v7, Stage II Uterine Corpus Cancer AJCC v7, Stage III Bladder Cancer AJCC v6 and v7, Stage III Breast Cancer AJCC v7, Stage III Colorectal Cancer AJCC v7, Stage III Esophageal Cancer AJCC v7, Stage III Gastric Cancer AJCC v7, Stage III Lung Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Pancreatic Cancer AJCC v6 and v7, Stage III Prostate Cancer AJCC v7, Stage III Uterine Corpus Cancer AJCC v7, Stage IV Bladder Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7, Stage IV Colorectal Cancer AJCC v7, Stage IV Esophageal Cancer AJCC v7, Stage IV Gastric Cancer AJCC v7, Stage IV Lung Cancer AJCC v7, Stage IV Ovarian Cancer AJCC v6 and v7, Stage IV Pancreatic Cancer AJCC v6 and v7, Stage IV Prostate Cancer AJCC v7, Stage IV Uterine Corpus Cancer AJCC v7, Thyroid Gland Carcinoma

01/25

02/25

T1DES, NCT02734277: Type 1 Diabetes Extension Study

Recruiting

N/A

111

National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN)

Type 1 Diabetes Mellitus, T1DM, T1D

03/25

NCT04928599: Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States

Suspended

N/A

100

Electronic Health Record Review, Interview, Survey Administration

Children's Oncology Group

Acute Lymphoblastic Leukemia

03/27

03/28

NCT03115333: DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma

Recruiting

N/A

146

Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging, DSC-MRI, Dynamic Susceptibility Contrast-Enhanced MRI, DYNAMIC SUSCEPTIBILITY-CONTRAST MRI

ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)

Gliosarcoma, Recurrent Glioblastoma

05/25

05/27

SWOG-S1823, NCT04435756: A Study of miRNA 371 in Patients With Germ Cell Tumors

Recruiting

N/A

956

Canada, US, RoW

Biomarker Analysis, Blood Product Collection, Collection, Blood Products

SWOG Cancer Research Network, National Cancer Institute (NCI)

Germ Cell Tumor, Metachronous Malignant Neoplasm, Seminoma, Stage I Testicular Cancer AJCC v8, Stage IA Testicular Cancer AJCC v8, Stage IB Testicular Cancer AJCC v8, Stage IS Testicular Cancer AJCC v8

06/26

10/26

HyMMy, NCT05879757: Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency

Recruiting

N/A

100

Europe, RoW

No Intervention

Takeda

Multiple Myeloma, Secondary Immunodeficiency (SID)

07/25

03/26

LEADER, NCT04985643: A Study of Real Life Treatment for Multiple Myeloma (MM)

Recruiting

N/A

111

RoW

Takeda

Multiple Myeloma

08/25

VARIETY, NCT05384080: A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland

Active, not recruiting

N/A

165

Europe

Takeda

Inflammatory Bowel Disease (IBD), Crohn's Disease, Ulcerative Colitis

08/25

NCT04314401: National Cancer Institute "Cancer Moonshot Biobank"

Recruiting

N/A

1000

Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Medical Chart Review, Chart Review

National Cancer Institute (NCI)

Acute Myeloid Leukemia, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Clinical Stage IV Esophageal Adenocarcinoma AJCC v8, Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Lung Non-Small Cell Carcinoma, Lung Small Cell Carcinoma, Malignant Solid Neoplasm, Metastatic Prostate Carcinoma, Multiple Myeloma, Stage III Lung Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8

09/25

SWOG-S2013, NCT04871542: Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

Recruiting

N/A

2062

Biospecimen Collection, Biological Sample Collection, Questionnaire Administration

SWOG Cancer Research Network, National Cancer Institute (NCI)

Malignant Solid Neoplasm

09/25

09/26

A151804, NCT04242095: Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

Recruiting

N/A

240

Biospecimen Collection, Medical Chart Review

Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)

Malignancy

10/25

NCT05013190: A Study of NINLARO® in Chinese Adults With Multiple Myeloma

Recruiting

N/A

320

RoW

No intervention

Takeda

Multiple Myeloma

10/25

NCT04961840: A Study to Assess Maternal and Fetal Outcomes After Taking Prucalopride During Pregnancy

Active, not recruiting

N/A

100

No Intervention

Takeda

Constipation, Pregnancy

12/25

S2108CD, NCT05455606: Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment

Recruiting

N/A

1182

Best Practice, standard of care, standard therapy, Chart Abstraction, Educational Intervention, Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational, Genomic Profile, genetic profile, Genome Profile, Genomic Profiling, Genomic Test, Genomic Testing, Interview, Questionnaire Administration, Tumor Board Review, multidisciplinary opinion

SWOG Cancer Research Network, National Cancer Institute (NCI)

Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm, Refractory Malignant Solid Neoplasm

12/25

NCT02402244: Project: Every Child for Younger Patients With Cancer

Recruiting

N/A

33000

Canada, US, RoW

Cytology Specimen Collection Procedure, Cytologic Sampling, Medical Chart Review, Chart Review

Children's Oncology Group, National Cancer Institute (NCI)

Carcinoma In Situ, Central Nervous System Neoplasm, Childhood Immature Teratoma, Childhood Langerhans Cell Histiocytosis, Childhood Mature Teratoma, Congenital Mesoblastic Nephroma, Desmoid Fibromatosis, Ganglioneuroma, Lymphoproliferative Disorder, Malignant Solid Neoplasm, Melanocytic Neoplasm, Myeloproliferative Neoplasm, Neuroendocrine Neoplasm, Stromal Neoplasm

12/30

NCT04799496: A Study of Kynteles Injection (Vedolizumab) in Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease or Chronic Pouchitis

Recruiting

N/A

600

RoW

Takeda

Inflammatory Bowel Diseases, Colitis, Ulcerative, Crohn Disease

01/26

CREDIT, NCT04960787: Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients and Their Spouses

Recruiting

N/A

522

Educational Intervention, Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational, Patient Navigation, Patient Navigator Program, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration

SWOG Cancer Research Network, National Cancer Institute (NCI)

Hematopoietic and Lymphoid Cell Neoplasm, Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm

03/26

10/26

CHOPIN, NCT05147181: A Study With Lanadelumab in Persons With Hereditary Angioedema (HAE) in Poland

Recruiting

N/A

Europe

Takeda

Hereditary Angioedema (HAE)

03/26

NCT04869280: Post-Marketing Study of Prucalopride Safety In Pregnancy

Recruiting

N/A

616

No Intervention

Takeda, The Organization of Teratology Information Specialists

Chronic Constipation

05/26

BV-MAZOVIA, NCT05100056: A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma

Recruiting

N/A

Europe

No Intervention

Takeda

Hodgkin Lymphoma

06/26

ALCHEMIST Screening, NCT02194738: Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The Trial)

Recruiting

N/A

8300

US, RoW

Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, JM8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Clinical Observation, observation, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Crizotinib, MET Tyrosine Kinase Inhibitor PF-02341066, PF-02341066, PF-2341066, PF02341066, Xalkori, Cytology Specimen Collection Procedure, Cytologic Sampling, Echocardiography, EC, Erlotinib, Gemcitabine Hydrochloride, dFdCyd, Difluorodeoxycytidine Hydrochloride, Gemcitabine HCI, Gemzar, LY-188011, LY188011, Nivolumab, ABP 206, BCD-263, BMS-936558, CMAB819, MDX-1106, NIVO, Nivolumab Biosimilar ABP 206, Nivolumab Biosimilar BCD-263, Nivolumab Biosimilar CMAB819, ONO-4538, Opdivo, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat, Pembrolizumab, BCD-201, GME 751, GME751, Keytruda, Lambrolizumab, MK-3475, Pembrolizumab Biosimilar BCD-201, Pembrolizumab Biosimilar GME751, Pembrolizumab Biosimilar QL2107, QL2107, SCH 900475, Pemetrexed, MTA, Multitargeted Antifolate, Pemfexy, Pemetrexed Disodium, Alimta, Almita, LY231514, N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic Acid Disodium Salt, Placebo Administration, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT

National Cancer Institute (NCI)

Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIA Lung Cancer AJCC v8, Stage IIB Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Cancer AJCC v8

09/26

NCT04838522: A Study of Prucalopride in Breastfeeding Women With Constipation

Recruiting

N/A

No Intervention

Takeda, UC San Diego Human Milk Research Biorepository

Chronic Constipation

12/26

NCT01034969: Firazyr® Patient Registry (Icatibant Outcome Survey - IOS)

Recruiting

N/A

3000

Europe, RoW

Shire, Takeda Development Center Americas, Inc.

Hereditary Angioedema (HAE)

01/27

NCT06112613: Mobile Health for Adherence in Breast Cancer Patients

Recruiting

N/A

410

Electronic Health Record Review, Health Promotion and Education, Health Telemonitoring, Interview, Patient Navigation, Patient Navigator Program, Survey Administration, Text Message-Based Navigation Intervention, Automated Text Message-Based Navigation, Text Message-Based Navigation

ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)

Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma, HER2-Negative Breast Carcinoma, Hormone Receptor-Positive Breast Carcinoma

07/27

NCT01503086: Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy

Active, not recruiting

N/A

Canada, US

Cognitive Assessment, Computer-Assisted Cognitive Training, Psychosocial Assessment and Care, Psychosocial Care/Assessment, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration

Children's Oncology Group, National Cancer Institute (NCI)

Brain Neoplasm, Recurrent Brain Neoplasm

03/27

ASPEN, NCT05568472: Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, Study

Recruiting

N/A

540

US, RoW

Best Practice, standard of care, standard therapy, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Endocrine Drug Therapy, Health Education, Questionnaire Administration, Symptom Specific Assessment Tool, Symptom Assessment Tool, Symptom-Specific Assessment Tool

SWOG Cancer Research Network, National Cancer Institute (NCI)

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma

05/27

05/28

DiRECT, NCT05364086: An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, Study

Recruiting

N/A

2100

University of Rochester NCORP Research Base, National Cancer Institute (NCI), Roswell Park Cancer Institute

Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm

05/27

ENTIRETY, NCT05735327: A Study of Brigatinib as Preferred First Therapy for Adults With Non-Small Cell Lung Cancer (NSCLC)

Recruiting

N/A

Europe

No intervention

Takeda

Non-small Cell Lung Cancer (NSCLC)

06/27

NRG-CC011, NCT05896189: Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Recruiting

N/A

386

Arm 1: Computerized Cognitive Training-Global Stimulation Games, Arm 2: Computerized Cognitive Training-Neuroplasticity Games

NRG Oncology, National Cancer Institute (NCI)

Breast Cancer, Cognitive Impairments

02/27

11/27

NCT05428345: A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea

Recruiting

N/A

600

RoW

Takeda

Ulcerative Colitis, Crohn's Disease, Inflammatory Bowel Disease (IBD)

11/27

NCT06002828: Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors

Recruiting

N/A

2000

Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration

ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)

Hodgkin Lymphoma, Non-Hodgkin Lymphoma

02/30

NCT03630536: TFE Renal Cell Carcinoma: A Prospective Registry and Translational Research Initiative

Recruiting

N/A

500

Children's Hospital Medical Center, Cincinnati

Renal Cell Carcinoma

05/28

NCT05705531: A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Recruiting

N/A

230

Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Electronic Health Record Review, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, Survey Administration

Children's Oncology Group, National Cancer Institute (NCI)

Cardiovascular Disorder, Clonal Hematopoiesis, Hodgkin Lymphoma

10/28

NCT05702645: A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

Recruiting

N/A

330

Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Clinical Evaluation, Clinical Assessment, Questionnaire Administration, Survey Administration

Children's Oncology Group, National Cancer Institute (NCI)

B Acute Lymphoblastic Leukemia Associated With Down Syndrome, Down Syndrome, Myeloid Leukemia Associated With Down Syndrome

12/28

NCT04158934: A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A

Active, not recruiting

N/A

207

Europe, US, RoW

ADYNOVI/ADYNOVATE, Antihaemophilic Factor [Recombinant] PEGylated rurioctocog alfa pegol, TAK-660, BAX 855

Baxalta now part of Shire

Hemophilia A

02/30

EA2185, NCT04239573: Comparing Two Methods to Follow Patients With Pancreatic Cysts

Recruiting

N/A

4606

Canada, US, RoW

Computed Tomography, CAT, CAT scan, Computerized Axial Tomography, computerized tomography, CT, CT scan, tomography, Endoscopic Ultrasound, endosonography, EUS, Magnetic Resonance Imaging, Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR Imaging, MRI, MRI Scan, NMR Imaging, NMRI, nuclear magnetic resonance imaging, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration

ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)

Pancreatic Carcinoma

07/33

PARADIGHM, NCT01922440: A Registry for Participants With Chronic Hypoparathyroidism

Active, not recruiting

N/A

1340

Europe, Canada, US

No intervention

Takeda, Takeda Development Center Americas, Inc.

Hypoparathyroidism

11/34

SWOG-S1703, NCT03723928: S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Recruiting

N/A

739

US, RoW

Usual care disease monitoring, Serum Tumor Marker directed disease monitoring, STMDDM, Quality-of-Life Assessment, Quality of Life Assessment, Anxiety Questionnaire Administration

SWOG Cancer Research Network, National Cancer Institute (NCI)

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative, Progesterone Receptor Positive, Prognostic Stage IV Breast Cancer AJCC v8, Elevated CA15-3 or CEA or CA27-29

12/30

12/36

FORTE, NCT05080673: Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Recruiting

N/A

9500

5-year and 10 Year Surveillance Colonoscopy after Qualifying Colonoscopy

NRG Oncology, National Cancer Institute (NCI)

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum

11/35

11/65

SOROCk, NCT04251052: A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Recruiting

N/A

2262

US, RoW

Bilateral Salpingectomy, Bilateral Salpingectomy with Oophorectomy, bilateral salpingo-oophorectomy, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Transvaginal Ultrasound, transvaginal sonography, TVS, TVU

NRG Oncology, National Cancer Institute (NCI)

Ovarian Carcinoma

06/36

06/37

NCT00904241: Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

Recruiting

N/A

10000

Europe, Canada, US, RoW

Cytology Specimen Collection Procedure, Cytologic Sampling, Laboratory Biomarker Analysis

Children's Oncology Group, National Cancer Institute (NCI)

Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4 Neuroblastoma, Stage 4S Neuroblastoma

01/00

AREN03B2, NCT00898365: Study of Kidney Tumors in Younger Patients

Recruiting

N/A

8000

Europe, Canada, US, RoW

Cytology Specimen Collection Procedure, Cytologic Sampling, Laboratory Biomarker Analysis

Children's Oncology Group, National Cancer Institute (NCI)

Adult Cystic Nephroma, Anaplastic Kidney Wilms Tumor, Angiolipoma, Cellular Congenital Mesoblastic Nephroma, Classic Congenital Mesoblastic Nephroma, Clear Cell Sarcoma of the Kidney, Congenital Mesoblastic Nephroma, Cystic Partially Differentiated Kidney Nephroblastoma, Diffuse Hyperplastic Perilobar Nephroblastomatosis, Extrarenal Rhabdoid Tumor, Kidney Medullary Carcinoma, Kidney Neoplasm, Kidney Oncocytoma, Kidney Wilms Tumor, Metanephric Adenofibroma, Metanephric Adenoma, Metanephric Stromal Tumor, Metanephric Tumor, Mixed Congenital Mesoblastic Nephroma, Ossifying Renal Tumor of Infancy, Papillary Renal Cell Carcinoma, Renal Cell Carcinoma, Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions, Rhabdoid Tumor of the Kidney, Wilms Tumor

01/00

NCT00736749: Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

Recruiting

N/A

5000

Assessment of Therapy Complications, Questionnaire Administration

Children's Oncology Group, National Cancer Institute (NCI)

Hematopoietic Cell Transplantation Recipient, Leukemia, Solid Tumor

01/00



	Diseases Companies Products Productz Mechanisms of Action Sites